Add-on or switch to repaglinide for type 2 diabetes with sitagliptin: Randomized controlled open-labelled trial.
Phase of Trial: Phase II
Latest Information Update: 21 Feb 2017
Price : $35 *
At a glance
- Drugs Repaglinide (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 18 Feb 2017 Status changed from recruiting to completed.
- 09 Aug 2013 New trial record